IL6 and temporal arteritis: IL-6 signaling has also been explored as a potential driver of VAP-1-associated endothelial alterations in the blood–brain barrier model, with the STAT3 pathway, which is known to significantly contribute to the pathogenesis of GCA (5, 102), being notably more activated in endothelial cells expressing VAP-1.